Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Magnera Corp files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2023
FY2025
FY2025
Revenue
1,596
866
928
916
1,085
1,491
2,275
1,386
2,187
3,204
Cost of revenue
657
736
780
769
940
1,343
1,995
1,256
1,950
2,867
Gross profit
144
130
148
148
145
149
280
130
237
337
Research and development
15
13
20
Selling, general and administrative
111
112
95
99.1
121
125
110
110
107
190
Operating expenses
1,963
1,905
2,850
Operating income
33.3
21.9
54.6
49.2
28.6
-164
69
2.71
-141
5
Interest expense
13.3
15.6
10.4
7.02
12.4
33.2
0
64.7
3
141
Interest income
0.24
0.56
1.12
0.4
0.07
0.41
1.49
Other non-operating income
-13.8
-14.7
-89.1
-16.8
-14.9
-40.4
3
-73.8
9
-30
Pre-tax income
19.5
7.28
-34.5
32.4
13.7
-204
72
-71.1
-135
-166
Income tax
25.1
7.72
-9.24
11.6
6.96
-10.3
34
7.01
19
-7
Net income
7.91
-178
-21.5
21.3
6.94
-194
38
-79.1
-154
-159
EBITDA
75.3
69.5
105
106
90
-97.2
238
66
34
211
EPS, basic
0.18
-4.06
-0.49
0.48
0.15
-4.33
1.19
-1.75
-4.84
-4.47
EPS, diluted
0.18
-4.06
-0.49
0.48
0.15
-4.33
1.19
-1.75
-4.84
-4.47
Shares, basic (weighted)
43.6
43.8
44.1
44.3
44.6
44.8
31.8
45.1
31.8
35.5
Shares, diluted (weighted)
44.4
43.8
44.1
44.6
44.9
44.8
31.8
45.1
31.8
35.5
Dividend per share
0.52
0.52
0.54
0.56
0.28
Balance sheet
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2023
FY2025
FY2025
Cash and equivalents
116
143
126
99.6
138
111
52.7
50.3
230
305
Receivables
111
120
124
123
170
196
168
171
359
522
Inventory
136
173
190
196
280
309
302
298
259
474
Other current assets
279
327
36.3
34.3
48.4
63.7
71.9
86.5
38
122
Total current assets
585
469
477
453
637
679
595
606
886
1,423
Property, plant and equipment
515
556
537
543
759
676
655
663
949
1,476
Lease right-of-use assets
11.7
11.8
27.2
25.4
26.5
25
49
62
Goodwill
82.7
153
151
164
236
105
794
108
624
663
Intangible assets
58.9
93.6
83.7
81.8
156
109
275
106
226
227
Other non-current assets
81.1
67.3
34.5
44.5
92.8
78.2
76.2
80.9
73
138
Total assets
1,731
1,340
1,284
1,287
1,881
1,647
1,533
1,564
2,807
3,989
Accounts payable
113
121
130
128
214
218
157
158
295
356
Accrued liabilities
162
90
Short-term debt
11.3
10.8
22.9
25.1
26.4
40.4
1.93
1.01
0
Total current liabilities
347
233
231
233
371
360
256
280
457
601
Long-term debt
470
401
337
288
738
793
848
853
0
1,952
Lease liabilities
39
45
Other non-current liabilities
79.6
88.4
84
110
141
121
123
121
94
281
Total liabilities
1,022
801
728
709
1,338
1,329
1,279
1,307
668
2,925
Total debt
483
413
362
315
776
844
868
872
1,952
1,952
Paid-in capital
62.6
62.2
59.9
63.3
64.8
60.7
58.2
58.8
0
1,417
Retained earnings
948
770
726
723
706
499
428
420
0
-159
Treasury stock
-162
-157
-152
-151
-148
-144
-140
-140
Other comprehensive income
-141
-137
-77.9
-58.7
-80.3
-97.9
-93.7
-82.5
-168
-195
Shareholders' equity
709
539
556
578
543
318
2,390
257
2,139
1,064
Total equity
709
539
556
578
543
318
2,390
257
2,139
1,064
Total liabilities and equity
1,731
1,340
1,284
1,287
1,881
1,647
1,533
1,564
2,807
3,989
Cash flow statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2023
FY2025
FY2025
Net income
7.91
-178
-21.5
21.3
6.94
-194
38
-79.1
-154
-159
Depreciation and amortization
42.1
47.5
50.8
56.6
61.4
66.7
169
63.2
175
206
Stock-based compensation
5.49
6.29
3.58
5.66
5.06
0.83
7
2.8
7
19
Deferred income tax
12
-7.7
-23
-2.07
-13.6
-24
-9
-12.2
-9
-27
Change in receivables
-4.15
-0.62
-5.47
9.56
-14.8
-35.3
63
21.6
-27
0
Change in inventory
1.52
-32.1
-17.4
6.86
-40
-44.4
49
9.61
-16
31
Change in payables
20.4
13.8
10.3
-7.23
65.8
16.4
-55
-62.7
40
-17
Cash from operations
53.2
-5.95
103
109
71
-40.8
257
-25.6
192
103
Capital expenditures
-80.8
-42.1
-27.8
-28.1
-30
-37.7
-88
-33.8
-72
-67
Acquisitions
-179
-1.38
0
-465
1.41
0
Cash from investing
-80.8
-218
-27.1
-26.8
-490
-33.1
-88
-37.1
-39
-8
Debt issued
249
0
46.8
0
262
Debt repaid
-9.77
-11.1
-16.7
-23.2
-26.1
-35.3
-4
-228
-2
-484
Stock issued
0
0
1,556
Dividends paid
-22.5
-22.8
-22.9
-23.5
-24.5
-18.8
0
Cash from financing
76.7
-91.4
-72.8
-100
462
46.9
-210
-0.95
-109
-21
Exchange rate effect
7.24
-5.56
-0.27
5.16
-5.42
-2.34
13
1.03
1
1
Net change in cash
56.4
-321
2.68
-12.9
38.1
-29.3
-28
-62.6
45
75
Free cash flow
-27.5
-48.1
75.1
80.9
40.9
-78.6
169
-59.4
120
36
Interest paid
13.9
15.8
10.2
6.18
6.96
33.2
59.2
124
Income taxes paid
9.34
15.2
14.2
-9.99
15.5
24.4
29
9.42
9
22
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $12.13 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
11.9%
Gross profit / revenue.
Operating margin
1.9%
Operating income / revenue.
EBITDA margin
7.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-3.0%
Pre-tax income / revenue.
Net margin
-3.4%
Net income / revenue.
FCF margin
3.4%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
5.2%
Cash from operations / revenue.
Return on equity (ROE)
-11.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-2.9%
Net income / average total assets.
Return on invested capital (ROIC)
1.9%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
6.2%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
0.5%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1.8%
Capital expenditures / revenue.
D&A / revenue
5.7%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
46.5%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
42.2%
Gross profit vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
520.6%
EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
-46.4%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-70.0%
Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-50.3%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
42.1%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
11.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.45x
Current assets / current liabilities.
Quick ratio
1.43x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.49x
(Cash + short-term investments) / current liabilities.
Debt / equity
1.87x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
49.6%
Total debt / total assets.
Liabilities / assets
73.5%
Total liabilities / total assets.
Net debt
$1.62B
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
6.48x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Days inventory + days sales outstanding - days payables.
Capex / operating cash flow
34.3%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$3.12
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$91.48
Revenue / diluted weighted shares.
FCF per share
$3.15
Free cash flow / diluted weighted shares.
Operating cash flow per share
$4.79
Cash from operations / diluted weighted shares.
Book value per share
$28.33
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.13x
Market cap / revenue.
P/B
0.43x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.43x
Market cap / tangible book value, when positive.
P/FCF
3.84x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
2.52x
Market cap / cash from operations, when positive.
EV/Sales
0.63x
Enterprise value / revenue.
EV/EBIT
32.6x
Enterprise value / operating income, when both are positive.
EV/EBITDA
8.22x
Enterprise value / EBITDA, when both are positive.
EV/FCF
18.2x
Enterprise value / free cash flow, when both are positive.
FCF yield
26.0%
Free cash flow / market cap.
Earnings yield
-25.8%
Net income / market cap (the inverse of P/E).
What was Magnera Corp's revenue in fiscal 2025?
Magnera Corp reported revenue of $3.20B for fiscal 2025, 46.5% higher than the year before.
Was Magnera Corp profitable in fiscal 2025?
No. It reported a net loss of $159.0M.
How much free cash flow did Magnera Corp generate in fiscal 2025?
Cash from operations of $103.0M minus capital expenditures of $67.0M left free cash flow of $36.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.